11![Clindamycin IV Currently marketed formulations of clindamycin IV1: DIN[removed]Company Clindamycin IV Currently marketed formulations of clindamycin IV1: DIN[removed]Company](https://www.pdfsearch.io/img/99f3ffa8dca21f9268367a95a591508c.jpg) | Add to Reading ListSource URL: medsask.usask.caLanguage: English - Date: 2013-12-03 09:25:12
|
---|
12![Work group report May, 2009 Cephalosporin Administration to Patients with a History of Penicillin Allergy Adverse Reactions to Drugs, Biologicals and Latex Committee Work Group Members: Roland Solensky, MD FAAAAI, Chair Work group report May, 2009 Cephalosporin Administration to Patients with a History of Penicillin Allergy Adverse Reactions to Drugs, Biologicals and Latex Committee Work Group Members: Roland Solensky, MD FAAAAI, Chair](https://www.pdfsearch.io/img/1bd6f29cef50b9e999d6634192fa00a9.jpg) | Add to Reading ListSource URL: www.aaaai.orgLanguage: English - Date: 2011-02-28 03:09:06
|
---|
13![Table 7. Drug Allergy Referral Guideline Patients with a history of penicillin allergy who have a significant probability of requiring future antibiotic therapy. Table 7. Drug Allergy Referral Guideline Patients with a history of penicillin allergy who have a significant probability of requiring future antibiotic therapy.](https://www.pdfsearch.io/img/f13b9c074e1f3c6ba8ec0556f340110e.jpg) | Add to Reading ListSource URL: www.aaaai.orgLanguage: English - Date: 2011-02-28 00:54:52
|
---|
14![Guidance for Industry Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing CrossContamination Guidance for Industry Non-Penicillin Beta-Lactam Drugs: A CGMP Framework for Preventing CrossContamination](https://www.pdfsearch.io/img/a3a8f4b71c16371586ee50d12a2b2f1d.jpg) | Add to Reading ListSource URL: www.fda.govLanguage: English |
---|
15![Drug Allergy: An Updated Practice Parameter Drug Allergy: An Updated Practice Parameter](https://www.pdfsearch.io/img/adbdedb43b74552a6d199950c889aba0.jpg) | Add to Reading ListSource URL: www.aaaai.orgLanguage: English - Date: 2011-02-28 15:25:22
|
---|